The ovarian stroma as a new frontier.
Kinnear HM, Tomaszewski CE, Chang AL, Moravek MB, Xu M, Padmanabhan V, Shikanov A.
Reproduction. 2020 Sep;160(3):R25-R39. doi: 10.1530/REP-19-0501.
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP, Fujita M, Yamada T, Simbolo M, Fassan M, Karlic R, Polak P, Kim J, Hatanaka Y, Maejima K, Lawlor RT, Nakanishi Y, Mitsuhashi T, Fujimoto A, Furuta M, Ruzzenente A, Conci S, Oosawa A, Sasaki-Oku A, Nakano K, Tanaka H, Yamamoto Y, Michiaki K, Kawakami Y, Aikata H, Ueno M, Hayami S, Gotoh K, Ariizumi SI, Yamamoto M, Yamaue H, Chayama K, Miyano S, Getz G, Scarpa A, Hirano S, Nakamura T, Nakagawa H.
J Hepatol. 2018 May;68(5):959-969. doi: 10.1016/j.jhep.2018.01.009. Epub 2018 Jan 31.
Hilar cell tumour of the ovary.
Anderson MC.
J Clin Pathol. 1972 Feb;25(2):106-10. doi: 10.1136/jcp.25.2.106.
Interobserver reproducibility of hilar soft tissue invasion in testicular germ cell tumours among genitourinary pathologists.
Wu DJ, Akgul M, Williamson SR, Pacheco R, Acosta A, Al-Obaidy K, Amin M, Berney D, Brimo F, Cheng L, Colecchia M, Compérat E, Cornejo K, Dhillon J, Downes M, Epstein JI, Hirsch MS, Jimenez R, Kaushal S, Lobo A, Lopez-Beltran A, Mehra R, Mohanty SK, Paner G, Rao P, Reuter V, Shah RB, Shen S, Smith S, Tretiakova M, Trpkov K, Wobker SE, Tamboli P, Zynger D, Sangoi AR.
Histopathology. 2025 Nov;87(5):677-686. doi: 10.1111/his.15504. Epub 2025 Jul 4.
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses.
Xia T, Li K, Niu N, Shao Y, Ding D, Thomas DL, Jing H, Fujiwara K, Hu H, Osipov A, Yuan C, Wolfgang CL, Thompson ED, Anders RA, He J, Mou Y, Murphy AG, Zheng L.
J Hematol Oncol. 2022 Mar 28;15(1):37. doi: 10.1186/s13045-022-01253-z.
Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1.
Bai M, Jiang N, Fu W, Huang C, Tian L, Mi N, Gao L, Ma H, Lu Y, Cao J, Zhang C, Yue P, Zhang Y, Lin Y, Meng W, Li X.
Hum Cell. 2024 Jan;37(1):364-375. doi: 10.1007/s13577-023-01003-4. Epub 2023 Nov 15.
[Pathology of cholangiocarcinoma].
Guedj N, Bedossa P, Paradis V.
Ann Pathol. 2010 Dec;30(6):455-63. doi: 10.1016/j.annpat.2010.10.004. Epub 2010 Nov 27.
Cholangiocarcinoma--current treatment options.
Friman S.
Scand J Surg. 2011;100(1):30-4. doi: 10.1177/145749691110000106.
[Surgery for small-cell lung cancer].
Al Zreibi C, Gibault L, Fabre E, Le Pimpec-Barthes F.
Rev Mal Respir. 2021 Oct;38(8):840-847. doi: 10.1016/j.rmr.2021.05.008. Epub 2021 Jun 5.
Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma.
Sang H, Li T, Li H, Liu J.
PLoS One. 2013 Nov 28;8(11):e81347. doi: 10.1371/journal.pone.0081347. eCollection 2013.
